Trial Profile
Phase 3 clinical study of AK-120 in patients with herpes zoster
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Famciclovir (Primary)
- Indications Herpes zoster
- Focus Adverse reactions; Therapeutic Use
- Sponsors Asahi Kasei Pharma Corp
- 10 Jun 2016 New trial record